Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

WHO Update: Lassa Fever in Germany

by Global Biodefense Staff
March 23, 2016
Lassa Fever Virus Virions

Lassa Fever Virus VirionsThe World Health Organization today provided an update on the two cases of Lassa fever reported from German health authorities.

The first case was a medical health care worker evacuated to Cologne, Germany from Togo on February  25 for treatment of complicated falciparum malaria. The patient passed away on the next day following multi-organ failure.

Autopsy findings were suggestive of haemorrhagic fever, and Lassa fever diagnosis was confirmed on March 9 at the Bernhard Nocht Institute for Tropical Medicine in Hamburg, Germany.

Funeral Home Exposure

The secondary case is a funeral home employee who handled the primary case’s corpse on March 2. The patient is reported to have worn gloves and does not recall being exposed to bodily fluids. Following the primary case’s diagnosis, he had been under home quarantine since March 9.

He already had had symptoms of an upper respiratory infection when he had contact with the corpse. Symptoms waxed and waned over the following days. The first laboratory test for Lassa fever on March 10 was negative by polymerase chain reaction (PCR).

When symptoms persisted, diagnostics were repeated and Lassa fever infection was confirmed by PCR on March 15. The patient has been transported to a special isolation unit in Frankfurt. He has no history of travel in the 21 days prior to the illness.

Four of his family members have voluntarily agreed to be quarantined in the same isolation unit. Further investigations are ongoing.

Public Health Response

Following laboratory confirmation of Lassa fever in the index case, 52 contacts have been identified and are currently under follow up. All contacts are either health care personnel or funeral home employees.

For 38 of these contacts, the maximum incubation period (21 days) expired on March 19. All contacts of the secondary case are also being followed up.

Source: World Health Organization, adapted.

Tags: Lassa Fever

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC